发明名称 |
Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions |
摘要 |
Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions. |
申请公布号 |
US9370586(B2) |
申请公布日期 |
2016.06.21 |
申请号 |
US201012977965 |
申请日期 |
2010.12.23 |
申请人 |
EKR Therapeutics, Inc. |
发明人 |
Duncan Michelle Renee;Gupta Supriya;Haas David Hartley;Stephens Norma V.;Zamiri Camellia |
分类号 |
A61K31/44;A61K47/48;A61K9/00;A61K31/4422;A61K31/455;A61K47/10;A61K47/12;A61K47/14;A61K47/26;A61K47/40;C08B37/16;C08L5/16;B82Y5/00 |
主分类号 |
A61K31/44 |
代理机构 |
Lowenstein Sandler LLP |
代理人 |
Lowenstein Sandler LLP |
主权项 |
1. A method for making a pharmaceutical composition for intravenous administration comprising:
preparing a pre-mixed aqueous solution with a pH from about 3.6 to about 4.4 comprising: a tonicity agent, a buffer, and from about 0.1 mg/mL to about 0.4 mg/mL nicardipine hydrochloride; and filling a pharmaceutically acceptable container with the aqueous solution such that the aqueous solution is in contact with non-polar polymers, the aqueous solution when stored in the container for at least three months at room temperature exhibiting (i) less than a 10% decrease in the concentration of nicardipine or pharmaceutically acceptable salt thereof and (ii) a total impurity formation of less than about 3%. |
地址 |
Cary NC US |